Paper37315744
Parallel evaluation of alternative skin barrier models and excised human skin for dermal absorption studies in vitro.
Salminen AT and 16 others. Toxicol In Vitro, 2023. Cited by 15 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Parallel evaluation of alternative skin barrier models and excised human skin for dermal absorption studies in vitro. Papers, record 37315744. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37315744
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Parallel evaluation of alternative skin barrier models and excised human skin for dermal absorption studies in vitro.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Skin Absorption | Major topic |
| Caffeine | Major topic |
| Humans | |
| Skin | |
| Epidermis | |
| Salicylic Acid | |
| Testosterone | |
| Water |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| FD999999 | Intramural FDA HHS | United States | PubMed | PubMed | |
| ZIATR000038 | NIH | NIH RePORTER |
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2,395,883 | Polarized integrin mediates human keratinocyte adhesion to basal lamina. | Proc Natl Acad Sci U S A | 1990 | https://conductscience.org/library/papers/2395883 | PubMed |
| 2 | 25,447,745 | Prediction of skin permeation by chemical compounds using the artificial membrane, Strat-M™. | Eur J Pharm Sci | 2015 | https://conductscience.org/library/papers/25447745 | PubMed |
| 3 | 18,522,484 | The use of reconstructed human epidermis for skin absorption testing: Results of the validation study. | Altern Lab Anim | 2008 | https://conductscience.org/library/papers/18522484 | PubMed |
| 4 | 31,867,769 | Measurement of the penetration of 56 cosmetic relevant chemicals into and through human skin using a standardized protocol. | J Appl Toxicol | 2020 | https://conductscience.org/library/papers/31867769 | PubMed |
| 5 | 32,882,340 | Partition coefficient and diffusion coefficient determinations of 50 compounds in human intact skin, isolated skin layers and isolated stratum corneum lipids. | Toxicol In Vitro | 2020 | https://conductscience.org/library/papers/32882340 | PubMed |
| 6 | 25,813,515 | Dissecting the formation, structure and barrier function of the stratum corneum. | Int Immunol | 2015 | https://conductscience.org/library/papers/25813515 | PubMed |
| 7 | 23,054,971 | Generic development of topical dermatologic products: formulation development, process development, and testing of topical dermatologic products. | AAPS J | 2013 | https://conductscience.org/library/papers/23054971 | PubMed |
| 8 | 26,063,051 | Pharmacokinetics-Based Approaches for Bioequivalence Evaluation of Topical Dermatological Drug Products. | Clin Pharmacokinet | 2015 | https://conductscience.org/library/papers/26063051 | PubMed |
| 9 | 16,945,325 | The skin barrier in healthy and diseased state. | Biochim Biophys Acta | 2006 | https://conductscience.org/library/papers/16945325 | PubMed |
| 10 | 4,622,425 | Skin permeability in vivo: comparison in rat, rabbit, pig and man. | J Invest Dermatol | 1972 | https://conductscience.org/library/papers/4622425 | PubMed |
| 11 | 22,517,028 | Prediction of concentration-time profile and its inter-individual variability following the dermal drug absorption. | J Pharm Sci | 2012 | https://conductscience.org/library/papers/22517028 | PubMed |
| 12 | 12,476,007 | Improvement of the experimental setup to assess cutaneous bioavailability on human skin models: dynamic protocol. | Skin Pharmacol Appl Skin Physiol | 2002 | https://conductscience.org/library/papers/12476007 | PubMed |
| 13 | 27,799,831 | Skin models for the testing of transdermal drugs. | Clin Pharmacol | 2016 | https://conductscience.org/library/papers/27799831 | PubMed |
| 14 | 35,689,632 | Microphysiological Systems Evaluation: Experience of TEX-VAL Tissue Chip Testing Consortium. | Toxicol Sci | 2022 | https://conductscience.org/library/papers/35689632 | PubMed |
| 15 | 12,490,374 | Modeling skin permeability to hydrophilic and hydrophobic solutes based on four permeation pathways. | J Control Release | 2003 | https://conductscience.org/library/papers/12490374 | PubMed |
| 16 | 823,268 | Relationship of topical dose and percutaneous absorption in rhesus monkey and man. | J Invest Dermatol | 1976 | https://conductscience.org/library/papers/823268 | PubMed |
| 17 | 9,363,373 | Targeted drug delivery to the skin and deeper tissues: role of physiology, solute structure and disease. | Clin Exp Pharmacol Physiol | 1997 | https://conductscience.org/library/papers/9363373 | PubMed |
| 18 | 1,094,962 | Percutaneous absorption of salicylic acid. | Arch Dermatol | 1975 | https://conductscience.org/library/papers/1094962 | PubMed |
| 19 | 21,455,015 | Percutaneous absorption in man: in vitro-in vivo correlation. | Skin Pharmacol Physiol | 2011 | https://conductscience.org/library/papers/21455015 | PubMed |
| 20 | 11,250,091 | Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption. | Int J Pharm | 2001 | https://conductscience.org/library/papers/11250091 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,909,403 | Barrier model selection alters apparent diclofenac permeation parameters: a controlled in vitro comparison of Strat-M® and a HaCaT-based epidermal construct. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42909403 | PubMed |
| 42,899,061 | A review of 3D In vitro skin models for psoriasis: from pathophysiology to advanced bioengineering. | Front Bioeng Biotechnol | 2026 | https://conductscience.org/library/papers/42899061 | PubMed |
| 42,797,327 | Pharmacokinetic Relevance of In Vitro Skin Models: Absorption, Cutaneous Distribution, Metabolism, and Clearance-like Removal in Dermal and Transdermal Drug Testing. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42797327 | PubMed |
| 42,791,852 | Optimization of a 3D Skin Equivalent Incorporating Melanocytes or Melanoma Cells for In Vitro Melanoma Research. | Bioengineering (Basel) | 2026 | https://conductscience.org/library/papers/42791852 | PubMed |
| 41,952,673 | A drug-drug co-amorphous formulation for enhanced solubility and transdermal absorption of rotundine. | Int J Pharm X | 2026 | https://conductscience.org/library/papers/41952673 | PubMed |
| 41,754,794 | Quality-by-Design Development of a Clofazimine-Pyrazinamide Dermal Emulsion and Its Diffusion Behavior in Strat-M® and Human Skin. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/41754794 | PubMed |
| 41,667,767 | In Vitro Permeation Testing of Sunscreens using Reconstructed Human Skin versus Human Cadaver Skin Models. | AAPS PharmSciTech | 2026 | https://conductscience.org/library/papers/41667767 | PubMed |
| 40,969,556 | 3D human epithelial models: a promising platform for studying Candida infections and novel antifungal therapeutic options. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/40969556 | PubMed |
| 40,892,119 | The Impact of Using Measured In Vitro Data to Develop Physiologically Based Pharmacokinetic Models of Dermal Absorption: An IVIVE Case Study. | AAPS J | 2025 | https://conductscience.org/library/papers/40892119 | PubMed |
| 40,746,730 | Assessment of drug permeability using a small airway microphysiological system. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40746730 | PubMed |
| 40,584,391 | Testosterone Deficiency and Sleep Deprivation as Risk Factors for Psoriasis: Insights From the National Health and Nutrition Examination Survey (NHANES) 2011-2014. | Clin Cosmet Investig Dermatol | 2025 | https://conductscience.org/library/papers/40584391 | PubMed |
| 40,583,047 | Surface Characterization of Skin Substitute Materials. | Skin Res Technol | 2025 | https://conductscience.org/library/papers/40583047 | PubMed |
| 39,536,613 | Diversity of human skin three-dimensional organotypic cultures. | Curr Opin Genet Dev | 2024 | https://conductscience.org/library/papers/39536613 | PubMed |
| 37,886,124 | Race, pigmentation, and the human skin barrier-considerations for dermal absorption studies. | Front Toxicol | 2023 | https://conductscience.org/library/papers/37886124 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37315744
GET https://conductscience.org/api/papers/v1/37315744/references?page=2